(VIANEWS) – FRONTLINE (FRO.OL), SPBK1 HELGELAND (HELG.OL), BOUVET (BOUV.OL) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| FRONTLINE (FRO.OL) | 11.18% | 2023-08-13 11:21:50 |
| SPBK1 HELGELAND (HELG.OL) | 8.14% | 2023-08-15 07:34:22 |
| BOUVET (BOUV.OL) | 4% | 2023-08-13 11:20:52 |
| SANOFI (SAN.PA) | 3.64% | 2023-08-15 07:03:05 |
| BEWI (BEWI.OL) | 2.77% | 2023-08-13 11:20:40 |
| BE SEMICONDUCTOR (BESI.AS) | 2.6% | 2023-08-15 07:01:06 |
| PERNOD RICARD (RI.PA) | 2.35% | 2023-08-15 07:01:41 |
| DIAGEO (DGE.PA) | 2.13% | 2023-08-13 07:46:13 |
Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. FRONTLINE (FRO.OL)
11.18% Foward Dividend Yield
FRONTLINE’s last close was kr183.70, 10.61% under its 52-week high of kr205.50. Intraday change was 1.36%.
Frontline plc, a shipping company, engages in the seaborne transportation of crude oil and oil products worldwide. It owns and operates oil and product tankers. As of December 31, 2022, the company operated a fleet of 70 vessels. It is also involved in the charter, purchase, and sale of vessels. The company was founded in 1985 and is based in Limassol, Cyprus.
Earnings Per Share
As for profitability, FRONTLINE has a trailing twelve months EPS of kr29.68.
PE Ratio
FRONTLINE has a trailing twelve months price to earnings ratio of 5.13. Meaning, the purchaser of the share is investing kr5.13 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.1%.
Volatility
FRONTLINE’s last week, last month’s, and last quarter’s current intraday variation average was 0.94%, 0.83%, and 2.06%.
FRONTLINE’s highest amplitude of average volatility was 1.16% (last week), 1.58% (last month), and 2.06% (last quarter).
More news about FRONTLINE.
2. SPBK1 HELGELAND (HELG.OL)
8.14% Foward Dividend Yield
SPBK1 HELGELAND’s last close was kr126.00, 10% below its 52-week high of kr140.00. Intraday change was -2.38%.
SpareBank 1 Helgeland provides various financial products and services to retail customers, small and medium enterprises, municipal authorities, and institutions in Norway. The company operates in two segments, Retail Market and Corporate Market. It offers savings, investment, and insurance products, as well as leasing and mortgage services. The company is also involved in owning, managing, and letting commercial properties. It operates through branches located in Mosjøen, Brønnøysund, and Sandnessjøen. The company was founded in 1860 and is headquartered in Mo i Rana, Norway.
Earnings Per Share
As for profitability, SPBK1 HELGELAND has a trailing twelve months EPS of kr13.6.
PE Ratio
SPBK1 HELGELAND has a trailing twelve months price to earnings ratio of 9.04. Meaning, the purchaser of the share is investing kr9.04 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.14%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Mar 30, 2023, the estimated forward annual dividend rate is 10.26 and the estimated forward annual dividend yield is 8.14%.
More news about SPBK1 HELGELAND.
3. BOUVET (BOUV.OL)
4% Foward Dividend Yield
BOUVET’s last close was kr64.60, 7.71% below its 52-week high of kr70.00. Intraday change was -0.33%.
Bouvet ASA provides IT and digital communication consultancy services for public and private sector companies in Norway, Sweden, and internationally. Bouvet ASA was founded in 1995 and is based in Oslo, Norway.
Earnings Per Share
As for profitability, BOUVET has a trailing twelve months EPS of kr3.09.
PE Ratio
BOUVET has a trailing twelve months price to earnings ratio of 19.51. Meaning, the purchaser of the share is investing kr19.51 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 60.9%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BOUVET’s stock is considered to be oversold (<=20).
Sales Growth
BOUVET’s sales growth is 12.3% for the current quarter and 9.7% for the next.
More news about BOUVET.
4. SANOFI (SAN.PA)
3.64% Foward Dividend Yield
SANOFI’s last close was €97.61, 7.2% under its 52-week high of €105.18. Intraday change was -1.13%.
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €6.65.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 14.51. Meaning, the purchaser of the share is investing €14.51 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.07%.
More news about SANOFI.
5. BEWI (BEWI.OL)
2.77% Foward Dividend Yield
BEWI’s last close was kr39.85, 40.52% below its 52-week high of kr67.00. Intraday change was 1.2%.
BEWi ASA provides packaging components and insulation solutions internationally. The company operates through RAW, Packaging & Components (P&C), Insulation & Construction (I&C), and Circular segments. The RAW segment produces raw materials, including white and grey expanded polystyrene, general purpose polystyrene, and BioFoam made from organic materials. The P&C segment manufactures and sells standard and customised solutions for various industrial sectors, including boxes for transportation of fish and other foods, protective packaging for fine goods, and technical and automotive components. The I&C segment manufactures a range of solutions for insulation and infrastructure, as well as systems for the building and construction industry. The Circular segment collects and recycles used material, including initiatives to raise knowledge and awareness about recycling and waste management. The company sells its products to food, pharmaceutical, automotive, hobby and leisure, residential housing, and thermal insulation industries. The company was founded in 1980 and is headquartered in Trondheim, Norway. BEWi ASA is a subsidiary of BEWI Invest AS.
Earnings Per Share
As for profitability, BEWI has a trailing twelve months EPS of kr1.69.
PE Ratio
BEWI has a trailing twelve months price to earnings ratio of 24.88. Meaning, the purchaser of the share is investing kr24.88 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.55%.
Sales Growth
BEWI’s sales growth is negative 87.5% for the present quarter and negative 88.1% for the next.
More news about BEWI.
6. BE SEMICONDUCTOR (BESI.AS)
2.6% Foward Dividend Yield
BE SEMICONDUCTOR’s last close was €106.65, 3.57% under its 52-week high of €110.60. Intraday change was -0.84%.
BE Semiconductor Industries N.V. engages in the development, manufacture, marketing, sale, and service of semiconductor assembly equipment for the semiconductor and electronics industries worldwide. The company's principal products include die attach equipment, such as single chip, multi-chip, multi module, flip chip, thermal compression bonding, fan out wafer level packaging, hybrid and embedded bridge die bonding, and die sorting systems; and packaging equipment, including conventional, ultra-thin, and wafer level molding, as well as trim and form, and singulation systems. Its principal products also comprise plating equipment, such as tin, copper, and precious metal and solar plating systems, as well as related process chemicals; and tooling, conversion kits, spare parts, and other services. The company's principal brand names include Datacon, Esec, Fico, and Meco. It offers its products primarily to multinational chip manufacturers, assembly subcontractors, and electronics and industrial companies. The company was incorporated in 1995 and is headquartered in Duiven, the Netherlands.
Earnings Per Share
As for profitability, BE SEMICONDUCTOR has a trailing twelve months EPS of €2.53.
PE Ratio
BE SEMICONDUCTOR has a trailing twelve months price to earnings ratio of 41.8. Meaning, the purchaser of the share is investing €41.8 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 36.48%.
Volume
Today’s last reported volume for BE SEMICONDUCTOR is 88835 which is 82.6% below its average volume of 510587.
Earnings Before Interest, Taxes, Depreciation, and Amortization
BE SEMICONDUCTOR’s EBITDA is 13.65.
More news about BE SEMICONDUCTOR.
7. PERNOD RICARD (RI.PA)
2.35% Foward Dividend Yield
PERNOD RICARD’s last close was €198.25, 9.06% under its 52-week high of €218.00. Intraday change was -1.59%.
Pernod Ricard SA produces and sells wines and spirits worldwide. The company offers whiskey, vodka, gin, rum, liqueur and bitters, champagne, tequila and mezcal, and aperitif under the brands 100 Pipers, Aberlour, Absolut, Absolut Elyx, Altos, ARARAT, Augier, Avion, Ballantine's, Becherovka, Beefeater, Blenders Pride, Brancott Estate, Campo Viejo, Ceder's, Chivas, Church Road, Clan Campbell, Del Maguey, George Wyndham, Green Spot, Havana Club, Imperial, Imperial Blue, Italicus, J.P. Wiser's, Jacob's Creek, Jameson, Jefferson's, Kahlúa, Kenwood, KI NO BI, Lillet, Long John, L'Orbe, Lot No. 40, Malfy, Malibu, Martell, Method & Madness, Midleton Very Rare, Minttu, Monkey 47, Mumm, Olmeca, Ostoya, Passport Scotch, Pastis 51, Pernod, Perrier-Jouët, Plymouth Gin, Powers, Rabbit Hole, Ramazzotti, Redbreast, Ricard, Royal Salute, Royal Stag, Scapa, Seagram's Gin, Secret Speyside, Smooth Ambler, Something Special, St Hugo, Stoneleigh, Suze, The Glenlivet, TX, Wyborowa, and Ysios. It also provides non-alcoholic beverages under the brands Ceder's, Suze Tonic 0%, Cinzano Spritz 0%, Pacific, Campo Viejo Sparkling 0%, and Jacob's Creek Unvined. The company was founded in 1805 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, PERNOD RICARD has a trailing twelve months EPS of €9.31.
PE Ratio
PERNOD RICARD has a trailing twelve months price to earnings ratio of 20.96. Meaning, the purchaser of the share is investing €20.96 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.84%.
Yearly Top and Bottom Value
PERNOD RICARD’s stock is valued at €195.10 at 22:50 EST, way below its 52-week high of €218.00 and way higher than its 52-week low of €170.85.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jul 5, 2023, the estimated forward annual dividend rate is 4.62 and the estimated forward annual dividend yield is 2.35%.
Volume
Today’s last reported volume for PERNOD RICARD is 64599 which is 79.92% below its average volume of 321807.
More news about PERNOD RICARD.
8. DIAGEO (DGE.PA)
2.13% Foward Dividend Yield
DIAGEO’s last close was €40.00, 17.36% below its 52-week high of €48.40. Intraday change was -1.48%.
Earnings Per Share
As for profitability, DIAGEO has a trailing twelve months EPS of €1.8.
PE Ratio
DIAGEO has a trailing twelve months price to earnings ratio of 22.22. Meaning, the purchaser of the share is investing €22.22 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 38.1%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 18.4%, now sitting on 16.92B for the twelve trailing months.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Mar 2, 2023, the estimated forward annual dividend rate is 0.89 and the estimated forward annual dividend yield is 2.13%.
Moving Average
DIAGEO’s worth is under its 50-day moving average of €41.19 and under its 200-day moving average of €42.40.
More news about DIAGEO.
